Author

A. Zarubica

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 4 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

B. Malissen· 3 shared M. Fabregue· 2 shared S. Sharkaoui· 2 shared A. Sansoni· 1 shared A. Wiedemann· 1 shared C. Degos· 1 shared C. Demerle· 1 shared C. Dong· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

B. Malissen

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

nanoCLAMP potently neutralizes SARS-CoV-2 and protects K18-hACE2 mice from infection

Q. Pagneux, N. Garnier, M. Fabregue, S. Sharkaoui, S. Mazzoli, I. Engelmann, R. Boukherroub, M. Strecker, E. Cruz, P. Ducos, A. Zarubica, R. Suderman, S. Szunerits

This paper develops a multi-epitope nanoCLAMP that neutralizes SARS-CoV-2 variants and protects mice from infection.

bioRxiv · Apr 3, 2023 · PreprintBioengineering

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

C. Demerle, L. Gorvel, M. Mello, S. Pastor, C. Degos, A. Zarubica, F. Angelis, F. FIORE, J. Nunes, B. Malissen, L. Greillier, G. Guittard, H. Luche, F. Barlesi, D. Olive

bioRxiv · Nov 4, 2022 · PreprintImmunology

Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine

S. Coleon, A. Wiedemann, M. Surenaud, C. Lacabaratz, S. Hue, M. Prague, M. Cervantes-Gonzalez, Z. Wang, J. Ellis, A. Sansoni, C. Pierini, Q. Bardin, M. Fabregue, S. Sharkaoui, P. Hoest, , Y. Levy

This study designs a pan-sarbecovirus vaccine targeting conserved epitopes and shows it induces cross-neutralizing antibodies and T-cell responses in mice and humans.

bioRxiv · Dec 28, 2021Immunology

Viral infection engenders bona fide and bystander lung memory B cell subsets through permissive selection

C. Gregoire, L. Spinelli, S. Villazala-Merino, L. Gil, M. Moussa, C. Dong, A. Zarubica, M. Fallet, J.-M. Navarro, B. Malissen, P. Milpied, M. Gaya

The paper identifies two distinct lung memory B cell subsets post-viral infection, showing they arise from different progenitors and are classified as virus-specific or bystander based on antigen specificity.

bioRxiv · Dec 14, 2021 · PreprintImmunology